Boothbay Fund Management’s Altimmune ALT Stock Holding History

Boothbay Fund Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-175,860	Closed	-$742K	–	1773
2023 Q1	$742K	Buy	175,860 +123,618	+237%	+$1.47M	0.02%	1117
2022 Q4	$859K	Sell	52,242 -34,669	-40%	-$389K	0.02%	967
2022 Q3	$1.11M	Sell	86,911 -41,372	-32%	-$611K	0.03%	825
2022 Q2	$1.5M	Buy	+128,283	New	+$791K	0.04%	662
2021 Q2	–	Sell	-19,495	Closed	-$275K	–	1825
2021 Q1	$275K	Buy	19,495 +1,628	+9%	+$26.3K	0.01%	1232
2020 Q4	$202K	Buy	17,867 +5,775	+48%	+$68K	0.01%	1105
2020 Q3	$160K	Buy	12,092 +81	+0.7%	+$1.62K	0.01%	959
2020 Q2	$129K	Buy	+12,011	New	+$66K	0.01%	853

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Boothbay Fund Management's ALT Position: Q2 2023 in Review

Boothbay Fund Management sold out of Altimmune (ALT) in Q2 2023, closing a stake of 175,860 shares — an estimated $742K sold.

Boothbay Fund Management first reported a position in ALT in Q2 2020 and held it in 8 quarters. The position peaked at $1.5M in Q2 2022. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

Boothbay Fund Management reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 175,860 Altimmune shares in Q2 2023, an estimated $742K.
Boothbay Fund Management first reported a position in Altimmune in Q2 2020 and held it in 8 quarters.
Boothbay Fund Management's Altimmune position peaked at $1.5M in Q2 2022.
120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.